InventisBio (SH:688382) Xin Lang Cai Jing·2025-08-29 02:04Group 1 - On August 28, Yifang Bio's stock fell by 2.08%, with a trading volume of 723 million yuan [1] - The financing data for Yifang Bio on the same day showed a financing purchase amount of 34.17 million yuan and a financing repayment of 38.78 million yuan, resulting in a net financing outflow of 4.61 million yuan [1] - As of August 28, the total balance of margin trading for Yifang Bio was 118 million yuan, which accounted for 0.75% of its market capitalization [1] Group 2 - As of June 30, Yifang Bio had 9,790 shareholders, a decrease of 7.28% from the previous period, while the average circulating shares per person increased by 7.85% to 40,990 shares [2] - For the first half of 2025, Yifang Bio reported revenue of 19.16 million yuan, representing a year-on-year growth of 28.85%, while the net profit attributable to shareholders was -119 million yuan, an increase of 44.25% year-on-year [2] - Among the top ten circulating shareholders as of June 30, 2025, several new institutional investors entered, including Huatai-PineBridge Innovation Medicine Mixed A and Hong Kong Central Clearing Limited [2]